Streetbeat News

Products Services

CHRW

CMND

MINM

NVIV

REVB

C.H. Robinson Worldwide, Inc. (CHRW) shares fell over 12% after reporting Q4 financial results below market expectations. Other stocks showed significant movement, with companies like Minim, Inc. (MINM) and Clearmind Medicine Inc. (CMND) experiencing substantial gains. Conversely, Revelation Biosciences, Inc. (REVB) and InVivo Therapeutics Holdings Corp. (NVIV) saw notable declines. The article also highlights stocks that moved due to earnings reports, strategic agreements, and other corporate actions.

Portfolio Pulse from Avi Kapoor

February 01, 2024 | 6:17 pm

NIO

XPEV

In January 2024, Chinese EV makers Li Auto, NIO, and XPeng reported significant delivery figures, showcasing their market performance and strategic directions. Li Auto led with a 105.8% YoY increase in deliveries, totaling 31,165 vehicles. NIO followed with an 18.2% increase, delivering 10,055 vehicles, and XPeng reported an 8,250 vehicle delivery, marking a 58% increase. NIO's strategic partnerships and expansion of its power swap network, XPeng's focus on ADAS technologies, and Li Auto's ambitious growth plans highlight their efforts to dominate the EV market.

Portfolio Pulse from Surbhi Jain

February 01, 2024 | 6:01 pm

ETH-USD

On Wednesday, 4,661.78 Ether (ETH) worth approximately $10.73 million was burned, permanently removing it from circulation. This action is part of the Ethereum blockchain's EIP-1159 upgrade implemented on August 5, 2021, which introduced a variable base fee for transactions that is burned. The current issuance rate of new Ether is 4% annually, expected to decrease to 0.5-1% with the Ethereum 2.0 upgrade, potentially making ETH a deflationary currency. The net annualized issuance rate for Ether was -3.58% yesterday.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 6:00 pm

AAPL

GOOG

In Q4 2023, Apple Inc. (AAPL) captured a 64% US smartphone market share, driven by iPhone 15 sales, while Android, powered by Alphabet Inc. (GOOG, GOOGL), saw a decline, especially in the sub-$300 segment. Apple's market dominance was further supported by strong holiday sales and strategic pricing of older models. The overall market growth and future outlook are tied to the US economic performance.

Portfolio Pulse from Rounak Jain

February 01, 2024 | 5:25 pm

Visa (NYSE:V) has partnered with Transak to enable direct cryptocurrency to fiat withdrawals, allowing users in 145 countries to cash out over 40 cryptocurrencies at 130 million merchant locations. This move, part of Visa's ongoing expansion into cryptocurrency services since 2020, has raised concerns regarding security, user experience, and its impact on the decentralized nature of digital currencies. Despite these concerns, the partnership is seen as a significant step towards mainstream cryptocurrency acceptance, offering users more flexibility and convenience.

Portfolio Pulse from Murtuza Merchant

February 01, 2024 | 5:12 pm

CELU

CMPR

NRBO

PTON

REVB

VLCN

U.S. stocks traded higher with the S&P 500 gaining 0.5%. Consumer staples shares rose by 1.4%, while financial shares fell by 0.9%. ISM manufacturing PMI rose to 49.1, the highest since Oct. 2022. Cimpress, NeuroBo Pharmaceuticals, and Celularity saw significant stock price increases following positive announcements. Conversely, Revelation Biosciences, Peloton Interactive, and Volcon experienced notable declines.

Portfolio Pulse from Avi Kapoor

February 01, 2024 | 5:04 pm

ENPH

Roth MKM has maintained its Buy rating for Enphase Energy (NASDAQ:ENPH) but lowered its price target from $150.00 to $140.00. Despite this, shares of Enphase Energy have risen 2.41% in the last 24 hours to $106.64. The new price target suggests a potential 31.28% increase from the current share price. Enphase Energy is a global energy technology company focusing on solar generation, storage, and communication solutions, with the majority of its revenue coming from the United States.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 5:00 pm

IONS

JP Morgan has maintained its Neutral rating for Ionis Pharmaceuticals (NASDAQ:IONS) but raised its price target from $52.00 to $55.00. Ionis Pharmaceuticals, a leader in antisense technology for drug development, has seen its shares increase by 0.62% in the last 24 hours to $51.71. The new price target represents a 6.36% potential upside. Ionis has successfully brought several drugs to market, including treatments for spinal muscular atrophy and ALS, through partnerships and its subsidiaries.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 5:00 pm

PTC

Rosenblatt has reaffirmed its Buy rating on PTC (NASDAQ:PTC), increasing the price target from $166.00 to $195.00. Despite a recent 2.02% decline in PTC's stock price to $177.00, the new target suggests a potential 10.17% upside. PTC specializes in high-end CAD and PLM software, along with IoT and AR solutions, primarily serving North America and Europe.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 5:00 pm

BTI

The FDA has issued warning letters to 14 online e-cigarette retailers for selling unauthorized vaping products. This action is part of the FDA's ongoing efforts to regulate the e-cigarette market and protect consumers, especially minors, from the dangers of vaping. The companies involved are not directly named, but the article hints that major tobacco companies like British American Tobacco (BTI), Altria Group (MO), and Philip Morris International (PM) may be indirectly affected due to their investments in the vaping industry.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 4:58 pm